Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial D-0017-2016

Fenofibric Acid Tablets 105 mg, Rx only, labeled as a) FIBRICOR (fenofibric acid) Tablets, 30-count bottles, NDC 13310-102-07, UPC 3 13310-102-07 5; b) FIBRICOR (fenofibric acid) Tablets, 90-count bottles, NDC 13310-102-90, UPC 3 13310-102-90 7; Manufactured for: AR SCIENTIFIC, INC., Philadelphia, PA 19124 USA; by: MUTUAL PHARMACEUTICAL CO., INC., Philadelphia, PA 19124 USA; and c) FIBRICOR (fenofibric acid) Tablets, 30-count bottles, NDC 49708-102-07, UPC 3 49708 10207 5; d) FIBRICOR (fenofibric acid) Tablets, 90-count bottles, NDC 49708-102-90, UPC 3 49708 10290 7; e) Fenofibric Acid Tablets, 30-count bottles, NDC 53489-678-07, UPC 3 53489 67807 0; f) Fenofibric Acid Tablets, 90-count bottles, NDC 53489-678-90, UPC 3 53489 67890 2; Manufactured by Mutual Pharmaceutical Company, Inc., Philadelphia, PA 19124, Distributed by: Sun Pharmaceutical Industries, Inc, Cranbury, NJ 08512; g) Fenofibric Acid Tablets, 30-count bottles, Professional Sample, NDC 53489-678-87, UPC 3 53489-678-87 2; Mutual Pharmaceutical Co., Inc., Philadelphia, PA 19124 USA.

Publicado el 21 de octubre de 2015 · Inicio del retiro: 1 de octubre de 2015

Resumen

FDA registra el retiro D-0017-2016 de medicamentos de Clase III, publicado el 21 de octubre de 2015 e iniciado el 1 de octubre de 2015. Empresa responsable: Tribute Pharmaceuticals US Inc.; Estado: Finalizado; Cantidad reportada: 140,607 bottles; Lote: Lot numbers: a) 6623102, Exp 01/16; b) 6623104, Exp 01/16; c) 6674403, Exp 01/17; d) 6674402, Exp 01/17; e) 6623001, 6623004, 6623103, Exp 01/16; 6639202, 6639203, 6639303, 6639304, Exp 04/16; 6674404, Exp 01/17; 6693301, Exp 05/17; f) 6623002, 6623005, 6623105, Exp 01/16; 6639301, 6639305, Exp 04/16; 6674401, Exp 01/17; 6693302, Exp 05/17; g) 6623003, 6623106, Exp 01/16; 6639201, Exp 04/16. La Clase III indica que no es probable que el producto cause consecuencias adversas para la salud.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Chemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug product.

Qué hacer

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Tribute Pharmaceuticals US Inc.
Distribuidor
Nationwide and Puerto Rico
Lote
Lot numbers: a) 6623102, Exp 01/16; b) 6623104, Exp 01/16; c) 6674403, Exp 01/17; d) 6674402, Exp 01/17; e) 6623001, 6623004, 6623103, Exp 01/16; 6639202, 6639203, 6639303, 6639304, Exp 04/16; 6674404, Exp 01/17; 6693301, Exp 05/17; f) 6623002, 6623005, 6623105, Exp 01/16; 6639301, 6639305, Exp 04/16; 6674401, Exp 01/17; 6693302, Exp 05/17; g) 6623003, 6623106, Exp 01/16; 6639201, Exp 04/16.
Clasificación de riesgo
Class III
Área (FDA)
drug
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Fenofibric Acid Tablets 105 mg, Rx only, labeled as a) FIBRICOR (fenofibric acid) Tablets, 30-count bottles, NDC 13310-102-07, UPC 3 13310-102-07 5; b) FIBRICOR (fenofibric acid) Tablets, 90-count bottles, NDC 13310-102-90, UPC 3 13310-102-90 7; Manufactured for: AR SCIENTIFIC, INC., Philadelphia, PA 19124 USA; by: MUTUAL PHARMACEUTICAL CO., INC., Philadelphia, PA 19124 USA; and c) FIBRICOR (fenofibric acid) Tablets, 30-count bottles, NDC 49708-102-07, UPC 3 49708 10207 5; d) FIBRICOR (fenofibric acid) Tablets, 90-count bottles, NDC 49708-102-90, UPC 3 49708 10290 7; e) Fenofibric Acid Tablets, 30-count bottles, NDC 53489-678-07, UPC 3 53489 67807 0; f) Fenofibric Acid Tablets, 90-count bottles, NDC 53489-678-90, UPC 3 53489 67890 2; Manufactured by Mutual Pharmaceutical Company, Inc., Philadelphia, PA 19124, Distributed by: Sun Pharmaceutical Industries, Inc, Cranbury, NJ 08512; g) Fenofibric Acid Tablets, 30-count bottles, Professional Sample, NDC 53489-678-87, UPC 3 53489-678-87 2; Mutual Pharmaceutical Co., Inc., Philadelphia, PA 19124 USA. fue retirado del mercado?

Sí. FDA publicó el retiro D-0017-2016 el 21 de octubre de 2015. Peligro reportado: Chemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug product.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit